Stereotactic Ablative Body Radiotherapy (SABR) for Oligoprogressive ER-Positive Breast Cancer (AVATAR): A Phase II Prospective Multicenter Trial
Steven David, Shankar Siva, Mathias Bressel, Jennifer Tan, Gerard G. Hanna, Reem Alomran, E. Yip, Cienne Morton, Megan C. Edmonds, Michelle White
Topics & Concepts
MedicineSABR volatility modelAblative caseBreast cancerRadiation therapyOncologyInternal medicineCancerStochastic volatilityFinancial economicsEconomicsVolatility (finance)Breast Cancer Treatment StudiesAdvanced Radiotherapy TechniquesCancer Genomics and Diagnostics